Lista de obras - Guilherme Baldo - Dominio Público Uruguay

A simple protocol for transfecting human mesenchymal stem cells

artículo científico publicado en 2018

Adult derived mononuclear bone marrow cells improve survival in a model of acetaminophen-induced acute liver failure in rats

artículo científico publicado en 2008

Aortic root dilatation in patients with mucopolysaccharidoses and the impact of enzyme replacement therapy

scientific article published on 22 August 2018

Aversive and non-aversive memory impairment in the mucopolysaccharidosis II mouse model

artículo científico publicado en 2017

Bone marrow derived cells decrease inflammation but not oxidative stress in an experimental model of acute myocardial infarction.

artículo científico publicado en 2010

Bone marrow mononuclear cell transplantation improves survival and induces hepatocyte proliferation in rats after CCl(4) acute liver damage

artículo científico publicado en 2010

CRISPR-Cas9-mediated gene editing in human MPS I fibroblasts

scientific article published on 03 August 2018

CRISPR/Cas9-directed genome editing of human MPS I fibroblasts

Cardiac pathology in Mucopolysaccharidosis I mice: Losartan modifies ERK1/2 activation during cardiac remodeling

artículo científico publicado en 2020

Cathepsin B inhibition attenuates cardiovascular pathology in mucopolysaccharidosis I mice

artículo científico publicado en 2018

Cathepsin B-associated Activation of Amyloidogenic Pathway in Murine Mucopolysaccharidosis Type I Brain Cortex

artículo científico publicado en 2020

Characterization of joint disease in mucopolysaccharidosis type I mice

artículo científico publicado en 2013

Chloramphenicol Enhances IDUA Activity on Fibroblasts from Mucopolysaccharidosis I Patients ⬇️

artículo científico publicado el 1 de enero de 2013

Clinical findings in Brazilian patients with adult GM1 gangliosidosis

artículo científico publicado en 2019

Cloramphenicol: A pharmacological chaperone?

scholarly article by Roberto Giugliani et al published February 2012 in Molecular Genetics and Metabolism

Comment on "report of 5 novel mutations of the α-L-iduronidase gene and comparison of Korean mutations in relation with those of Japan or China in patients with mucopolysaccharidosis I"

article

Deleterious effects of interruption followed by reintroduction of enzyme replacement therapy on a lysosomal storage disorder

artículo científico publicado en 2016

Diagnosis and therapy options in mucopolysaccharidosis II (Hunter syndrome)

Diagnostic and treatment strategies in mucopolysaccharidosis VI.

artículo científico publicado en 2015

Effects of cryopreservation and hypothermic storage on cell viability and enzyme activity in recombinant encapsulated cells overexpressing alpha-L-iduronidase.

artículo científico publicado en 2010

Effects of enzyme replacement therapy started late in a murine model of mucopolysaccharidosis type I

artículo científico publicado en 2015

Effects of gene therapy on cardiovascular symptoms of lysosomal storage diseases

artículo científico publicado en 2019

Emerging drugs for the treatment of mucopolysaccharidoses.

artículo científico publicado en 2016

Enzyme replacement therapy started at birth improves outcome in difficult-to-treat organs in mucopolysaccharidosis I mice

artículo científico publicado en 2013

Evidence for inflammasome activation in the brain of mucopolysaccharidosis type II mice

artículo científico publicado en 2020

Evidence of a progressive motor dysfunction in Mucopolysaccharidosis type I mice

artículo científico publicado en 2012

FREQÜÊNCIA DE OVOS DE Toxocara spp. EM TRÊS PARQUES PÚBLICOS DA CIDADE DE PORTO ALEGRE, RIO GRANDE DO SUL, BRASIL

artículo científico publicado en 2008

Gene delivery strategies for the treatment of mucopolysaccharidoses

artículo científico

Gene editing of MPS I human fibroblasts by co-delivery of a CRISPR/Cas9 plasmid and a donor oligonucleotide using nanoemulsions as nonviral carriers.

artículo científico publicado en 2017

Genome Editing for Mucopolysaccharidoses

artículo científico publicado en 2020

In vitro correction of ARSA deficiency in human skin fibroblasts from metachromatic leukodystrophy patients after treatment with microencapsulated recombinant cells

artículo científico publicado en 2008

In vivo genome editing of mucopolysaccharidosis I mice using the CRISPR/Cas9 system

scientific article published on 28 August 2018

Intra-articular nonviral gene therapy in mucopolysaccharidosis I mice

artículo científico publicado en 2018

Intraperitoneal implant of recombinant encapsulated cells overexpressing alpha-L-iduronidase partially corrects visceral pathology in mucopolysaccharidosis type I mice

artículo científico publicado en 2012

Losartan improves aortic dilatation and cardiovascular disease in mucopolysaccharidosis I.

artículo científico publicado en 2017

Lysosomal diseases: Overview on current diagnosis and treatment

artículo científico publicado en 2019

Lysosomal enzymes may cross the blood-brain-barrier by pinocytosis: implications for enzyme replacement therapy

artículo científico publicado en 2014

Mucopolysaccharidosis Type I

artículo científico publicado en 2020

Nanotechnology applied to treatment of mucopolysaccharidoses.

artículo científico publicado en 2016

Nasal Administration of Cationic Nanoemulsions as Nucleic Acids Delivery Systems Aiming at Mucopolysaccharidosis Type I Gene Therapy

scientific article published on 26 September 2018

Neonatal hyperglycemia induces cell death in the rat brain

artículo científico publicado en 2017

Neonatal nonviral gene editing with the CRISPR/Cas9 system improves some cardiovascular, respiratory, and bone disease features of the mucopolysaccharidosis I phenotype in mice

scientific article published on 11 December 2019

Neurological manifestations of lysosomal disorders and emerging therapies targeting the CNS

artículo científico publicado en 2017

Pathogenesis of aortic dilatation in mucopolysaccharidosis VII mice may involve complement activation

artículo científico publicado en 2011

Pathogenesis of lumbar spine disease in mucopolysaccharidosis VII.

artículo científico publicado en 2012

Pathogenesis of mitral valve disease in mucopolysaccharidosis VII dogs.

artículo científico publicado en 2013

Phase I and II clinical trials for the mucopolysaccharidoses.

artículo científico publicado en 2017

Physicochemical properties of cationic nanoemulsions and liposomes obtained by microfluidization complexed with a single plasmid or along with an oligonucleotide: Implications for CRISPR/Cas technology

artículo científico publicado en 2018

Pitfalls in the prenatal diagnosis of mucolipidosis II alpha/beta: A case report

artículo científico publicado en 2014

Placenta analysis of prenatally diagnosed patients reveals early GAG storage in mucopolysaccharidoses II and VI.

artículo científico publicado en 2011

Precision Medicine for Lysosomal Disorders

artículo científico publicado en 2020

Prevalence of the serpin peptidase inhibitor (alpha-1-antitrypsin) PIS and PIZ alleles in Brazilian children with liver disease

article

Progressive eye pathology in mucopolysaccharidosis type I mice and effects of enzyme replacement therapy

artículo científico publicado en 2020

Progressive heart disease in mucopolysaccharidosis type I mice may be mediated by increased cathepsin B activity

artículo científico publicado en 2017

Recombinant encapsulated cells overexpressing alpha-L-iduronidase correct enzyme deficiency in human mucopolysaccharidosis type I cells

artículo científico publicado en 2011

Retroviral-vector-mediated gene therapy to mucopolysaccharidosis I mice improves sensorimotor impairments and other behavioral deficits

artículo científico publicado en 2012

Shotgun proteomics reveals possible mechanisms for cognitive impairment in Mucopolysaccharidosis I mice

artículo científico publicado en 2014

Subcutaneous implantation of microencapsulated cells overexpressing α-L-iduronidase for mucopolysaccharidosis type I treatment

artículo científico publicado en 2017

The Latin American School of Human and Medical Genetics: promoting education and collaboration in genetics and ethics applied to health sciences across the continent

artículo científico publicado en 2015

The challenges of organizing an international course in Latin America

artículo científico publicado en 2014

The progression of pulmonary arterial hypertension induced by monocrotaline is characterized by lung nitrosative and oxidative stress, and impaired pulmonary artery reactivity

artículo científico publicado en 2020

Therapeutic Options for Mucopolysaccharidosis II (Hunter Disease)

artículo científico publicado en 2020

Therapy for mucopolysaccharidosis VI: (Maroteaux-Lamy syndrome) present status and prospects.

artículo científico publicado en 2014

Visual and Thermal Image Processing for Facial Specific Landmark Detection to Infer Emotions in a Child-Robot Interaction

scientific article published on 26 June 2019

Lista de obras de Guilherme Baldo

A simple protocol for transfecting human mesenchymal stem cells

Adult derived mononuclear bone marrow cells improve survival in a model of acetaminophen-induced acute liver failure in rats

Aortic root dilatation in patients with mucopolysaccharidoses and the impact of enzyme replacement therapy

Aversive and non-aversive memory impairment in the mucopolysaccharidosis II mouse model

Bone marrow derived cells decrease inflammation but not oxidative stress in an experimental model of acute myocardial infarction.

Bone marrow mononuclear cell transplantation improves survival and induces hepatocyte proliferation in rats after CCl(4) acute liver damage

CRISPR-Cas9-mediated gene editing in human MPS I fibroblasts

CRISPR/Cas9-directed genome editing of human MPS I fibroblasts

Cardiac pathology in Mucopolysaccharidosis I mice: Losartan modifies ERK1/2 activation during cardiac remodeling

Cathepsin B inhibition attenuates cardiovascular pathology in mucopolysaccharidosis I mice

Cathepsin B-associated Activation of Amyloidogenic Pathway in Murine Mucopolysaccharidosis Type I Brain Cortex

Characterization of joint disease in mucopolysaccharidosis type I mice

Chloramphenicol Enhances IDUA Activity on Fibroblasts from Mucopolysaccharidosis I Patients ⬇️

Clinical findings in Brazilian patients with adult GM1 gangliosidosis

Cloramphenicol: A pharmacological chaperone?

Comment on "report of 5 novel mutations of the α-L-iduronidase gene and comparison of Korean mutations in relation with those of Japan or China in patients with mucopolysaccharidosis I"

Deleterious effects of interruption followed by reintroduction of enzyme replacement therapy on a lysosomal storage disorder

Diagnosis and therapy options in mucopolysaccharidosis II (Hunter syndrome)

Diagnostic and treatment strategies in mucopolysaccharidosis VI.

Effects of cryopreservation and hypothermic storage on cell viability and enzyme activity in recombinant encapsulated cells overexpressing alpha-L-iduronidase.

Effects of enzyme replacement therapy started late in a murine model of mucopolysaccharidosis type I

Effects of gene therapy on cardiovascular symptoms of lysosomal storage diseases

Emerging drugs for the treatment of mucopolysaccharidoses.

Enzyme replacement therapy started at birth improves outcome in difficult-to-treat organs in mucopolysaccharidosis I mice

Evidence for inflammasome activation in the brain of mucopolysaccharidosis type II mice

Evidence of a progressive motor dysfunction in Mucopolysaccharidosis type I mice

FREQÜÊNCIA DE OVOS DE Toxocara spp. EM TRÊS PARQUES PÚBLICOS DA CIDADE DE PORTO ALEGRE, RIO GRANDE DO SUL, BRASIL

Gene delivery strategies for the treatment of mucopolysaccharidoses

Gene editing of MPS I human fibroblasts by co-delivery of a CRISPR/Cas9 plasmid and a donor oligonucleotide using nanoemulsions as nonviral carriers.

Genome Editing for Mucopolysaccharidoses

In vitro correction of ARSA deficiency in human skin fibroblasts from metachromatic leukodystrophy patients after treatment with microencapsulated recombinant cells

In vivo genome editing of mucopolysaccharidosis I mice using the CRISPR/Cas9 system

Intra-articular nonviral gene therapy in mucopolysaccharidosis I mice

Intraperitoneal implant of recombinant encapsulated cells overexpressing alpha-L-iduronidase partially corrects visceral pathology in mucopolysaccharidosis type I mice

Losartan improves aortic dilatation and cardiovascular disease in mucopolysaccharidosis I.

Lysosomal diseases: Overview on current diagnosis and treatment

Lysosomal enzymes may cross the blood-brain-barrier by pinocytosis: implications for enzyme replacement therapy

Mucopolysaccharidosis Type I

Nanotechnology applied to treatment of mucopolysaccharidoses.

Nasal Administration of Cationic Nanoemulsions as Nucleic Acids Delivery Systems Aiming at Mucopolysaccharidosis Type I Gene Therapy

Neonatal hyperglycemia induces cell death in the rat brain

Neonatal nonviral gene editing with the CRISPR/Cas9 system improves some cardiovascular, respiratory, and bone disease features of the mucopolysaccharidosis I phenotype in mice

Neurological manifestations of lysosomal disorders and emerging therapies targeting the CNS

Pathogenesis of aortic dilatation in mucopolysaccharidosis VII mice may involve complement activation

Pathogenesis of lumbar spine disease in mucopolysaccharidosis VII.

Pathogenesis of mitral valve disease in mucopolysaccharidosis VII dogs.

Phase I and II clinical trials for the mucopolysaccharidoses.

Physicochemical properties of cationic nanoemulsions and liposomes obtained by microfluidization complexed with a single plasmid or along with an oligonucleotide: Implications for CRISPR/Cas technology

Pitfalls in the prenatal diagnosis of mucolipidosis II alpha/beta: A case report

Placenta analysis of prenatally diagnosed patients reveals early GAG storage in mucopolysaccharidoses II and VI.

Precision Medicine for Lysosomal Disorders

Prevalence of the serpin peptidase inhibitor (alpha-1-antitrypsin) PI*S and PI*Z alleles in Brazilian children with liver disease

Progressive eye pathology in mucopolysaccharidosis type I mice and effects of enzyme replacement therapy

Progressive heart disease in mucopolysaccharidosis type I mice may be mediated by increased cathepsin B activity

Recombinant encapsulated cells overexpressing alpha-L-iduronidase correct enzyme deficiency in human mucopolysaccharidosis type I cells

Retroviral-vector-mediated gene therapy to mucopolysaccharidosis I mice improves sensorimotor impairments and other behavioral deficits

Shotgun proteomics reveals possible mechanisms for cognitive impairment in Mucopolysaccharidosis I mice

Subcutaneous implantation of microencapsulated cells overexpressing α-L-iduronidase for mucopolysaccharidosis type I treatment

The Latin American School of Human and Medical Genetics: promoting education and collaboration in genetics and ethics applied to health sciences across the continent

The challenges of organizing an international course in Latin America

The progression of pulmonary arterial hypertension induced by monocrotaline is characterized by lung nitrosative and oxidative stress, and impaired pulmonary artery reactivity

Therapeutic Options for Mucopolysaccharidosis II (Hunter Disease)

Therapy for mucopolysaccharidosis VI: (Maroteaux-Lamy syndrome) present status and prospects.

Visual and Thermal Image Processing for Facial Specific Landmark Detection to Infer Emotions in a Child-Robot Interaction

Prevalence of the serpin peptidase inhibitor (alpha-1-antitrypsin) PIS and PIZ alleles in Brazilian children with liver disease